RO5083945
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for RO5083945, covering 2016-01-01 to 2022-11-17. Get the full timeline:
Most recent: Clinical Trial Update: A Study of RO5083945 in Combination With FOLFIRI Versus FOLFIRI Plus Cetuximab or FOLFIRI Alone as Second Line Treatment in Patients With Metastatic Colorectal Cancer [Phase 2]